Close
  Indian J Med Microbiol
 

Figure 2: Changes in noninflammatory lesion count in groups A and B. Noninflammatory lesion count (mean ± standard deviation) in Group A are 17.42 ± 0.9, 10.65 ± 0.5, 6.35 ± 0.4, 3.11 ± 0.3 at weeks 0,4, 8, 12 respectively; in Group B are 17.68 ± 0.9, 6.94 ± 0.8, 2.64 ± 0.3, 0.94 ± 0.2 at weeks 0,4, 8, 12 respectively. *P< 0.05 and **P < 0.05-weeks 4, 8,12 versus week 0 in Groups A and B respectively. Intergroup comparison of noninflammatory lesion count levels at weeks 4, 8, and 12: $P< 0.05 - Group A versus B at week 4. #P< 0.05 - Group A versus B at week 8. ##P< 0.05 - Group A versus B at week 12

Figure 2: Changes in noninflammatory lesion count in groups A and B. Noninflammatory lesion count (mean ± standard deviation) in Group A are 17.42 ± 0.9, 10.65 ± 0.5, 6.35 ± 0.4, 3.11 ± 0.3 at weeks 0,4, 8, 12 respectively; in Group B are 17.68 ± 0.9, 6.94 ± 0.8, 2.64 ± 0.3, 0.94 ± 0.2 at weeks 0,4, 8, 12 respectively. *<i>P</i>< 0.05 and **<i>P</i> < 0.05-weeks 4, 8,12 versus week 0 in Groups A and B respectively. Intergroup comparison of noninflammatory lesion count levels at weeks 4, 8, and 12: <sup>$</sup><i>P</i>< 0.05 - Group A versus B at week 4. <sup>#</sup><i>P</i>< 0.05 - Group A versus B at week 8. <sup>##</sup><i>P</i>< 0.05 - Group A versus B at week 12